Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calonest-Plus is a multi-ingredient nutritional supplement developed and marketed by Prisure Medicare, an Indian pharmaceutical company. The product is formulated as an oral soft gelatin capsule or tablet containing a combination of vitamins and minerals: elemental calcium (from calcium carbonate), Vitamin D3 (as calcitriol), methylcobalamin (Vitamin B12), L-methylfolate, Vitamin K2-7, magnesium, and zinc. It is indicated for the maintenance of bone and joint health, specifically to reduce joint inflammation and pain, enhance bone strength and flexibility, and prevent the degeneration of articular cartilage. Calonest-Plus is primarily positioned within the orthopedic therapeutic segment in the Indian market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Calonest-Plus.